“Snake Pneumonia” – Coronavirus Outbreak in China Traced to Snakes by Genetic Analysis
Patients who became infected with the virus were exposed to wildlife animals at a wholesale market, where seafood, poultry, snakes, bats, and farm animals were sold.
Emerging viral infections — from bird flu to Ebola to Zika infections — pose major threats to global public health, and understanding their origins can help investigators design defensive strategies against future outbreaks. A new study provides important insights on the potential origins of the most recent outbreak of viral pneumonia in China, which started in the middle of December and now is spreading to Hong Kong, Singapore, Thailand, and Japan. The findings are published early online in the Journal of Medical Virology.
The study notes that patients who became infected with the virus — which is a type of virus called a coronavirus and was named 2019-nCoV by the World Health Organization — were exposed to wildlife animals at a wholesale market, where seafood, poultry, snakes, bats, and farm animals were sold.
By conducting a detailed genetic analysis of the virus and comparing it with available genetic information on different viruses from various geographic locations and host species, the investigators concluded that the 2019-nCoV appears to be a virus that formed from a combination of a coronavirus found in bats and another coronavirus of unknown origin. The resulting virus developed a mix or “recombination” of a viral protein that recognizes and binds to receptors on host cells. Such recognition is key to allowing viruses to enter host cells, which can lead to infection and disease.
Finally, the team uncovered evidence that the 2019-nCoV likely resided in snakes before being transmitted to humans. Recombination within the viral receptor-binding protein may have allowed for cross-species transmission from snake to humans.
“Results derived from our evolutionary analysis suggest for the first time that snake is the most probable wildlife animal reservoir for the 2019-nCoV,” the authors wrote. “New information obtained from our evolutionary analysis is highly significant for effective control of the outbreak caused by the 2019-nCoV-induced pneumonia.”
An accompanying editorial notes that although the ultimate control of emerging viral infections requires the discovery and development of effective vaccines and/or antiviral drugs, currently licensed antiviral drugs should be tested against the 2019-nCoV.
Concerned about this viral infection from China that may have originated in snakes and bats? Read Research Underway to Address Threat of Novel Coronavirus That Recently Emerged in China.
Reference: “Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross‐species transmission from snake to human” by Wei Ji, Wei Wang, Xiaofang Zhao, Junjie Zai and Xingguang Li, 22 January 2020, Journal of Medical Virology.
- Air Filter Created That Can Kill the Coronavirus – 99.8% Effective on SARS-CoV-2
- Powerful Medical Benefit: The Right Way to Breathe During the Coronavirus Pandemic
- Self-Isolation May Increase Your Susceptibility to COVID-19 – Here’s Why
- Compounds Identified That Halt COVID-19 Virus Replication by Targeting Key Viral Enzyme
- Safety Concerns Dim Mental Health Benefits of Parks
- The US Isn’t in a Second Wave of Coronavirus – The First Wave Never Ended
- Researchers Publish Galaxy Zoo 2 Catalog, Data on More than 300,000 Nearby Galaxies
- Astronomers Identify a New Kind of Galaxy, “Green Bean Galaxies”
- Nanoparticles in Food Affect Iron Absorption
- Yale Researchers Show Parents Underestimate Their Children’s Weight
- Study Shows Six-Month Old Babies Have a Sense of Probability
- VLA and Chandra Reveal the Shocking Results of Galaxy Cluster Collisions
- NanoVelcro Device Grabs Single Cancer Cells from Blood
- ESO Views Star-Forming Region Lupus 3, Most Detailed Image to Date (4K UHD Video)